Compound Rehmannia prescription improves the neurobehavioral changes of Parkinson's disease rat

来源 :2nd International Neural Regeneration Symposium(INRS2012)(第二 | 被引量 : 0次 | 上传用户:wodetiantian3321
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  This study was designed to observe the effects of compound Rehmannia prescription on the neuroethology in Parkinsons disease rats with levodopa-induced dyskinesia.
其他文献
会议
会议
Permanent bilateral occlusion of the common carotid arteries in rats is an established experimental model to investigate chronic cerebral hypoperfusion on cognitive function and neurodegenerative proc
Reactive gliosis commonly occurs in brain injury, which is characterized by cellular hypertrophy and glial cell proliferation.In the central nervous system and cerebral-vessel trauma process, thrombin
The effects of ANEPⅢ, a new recombinant neurotoxic peptide, on behavior and brain neuronal activity in animal studies have previously been described.However, whether ANEPⅢ can directly protect neurons
Antitumor-analgesic peptide is a novel recombinant polypeptide with strong analgesic and antitumor effects.Antitumor-analgesic peptide inhibited the writhing response in a dose-dependent manner in a p
Phencyclidine (PCP), an open channel antagonist of the NMDA subtype of glutamate receptor, induces schizophrenia-like behavior in humans and animals and increases glutamate and dopamine release in the
In addition to its key role in complex motor function, the cerebellum is increasingly recognized to have a role in cognition.Thus, congenital, injury or toxicity-induced cerebellar abnormalities have
Bone marrow-derived mesenchymal stem cells (MSCs) are capable of differentiating into multiple cell types.Cell therapy using MSCs has been applied in treating many disorders such as bone defects, dela
Recent studies have shown a modern in vivo optical imaging to detect matrix metallopeptidase (MMP) activation in the ischemic brain.